Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025.
Tata Chemicals Ltd. key Products/Revenue Segments include Salt, Refined Sodium Bicarbonate, Others, Specialty Chemicals for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback